← Back to Search

Behavioural Intervention

Resilience Program for High-Risk Cancer Individuals (PreCharge Trial)

Research Sponsored by Pro-Change Behavior Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Never having been diagnosed with cancer
Identified as having Hereditary Cancer Syndrome
Screening 3 weeks
Treatment Varies
Follow Up 1 month follow-up
Awards & highlights


This trial will study the effectiveness of a program called PreCharge in boosting resilience among people who are at high risk of developing cancer due to inherited genetic mutations. The program will be delivered through text messaging to

Who is the study for?
This trial is for adults over 18 in the U.S. who have a Hereditary Cancer Syndrome but haven't had cancer themselves. They must speak English, score low on a resilience scale, and be able to receive text messages.Check my eligibility
What is being tested?
The study tests 'PreCharge,' a program aimed at boosting resilience among previvors through bi-directional text messaging. It focuses on fostering positivity, social connections, and purpose while addressing anxiety related to cancer screenings.See study design
What are the potential side effects?
Since PreCharge is a non-medical intervention focusing on communication and mental support via texting, it does not have physical side effects like drugs or medical treatments would.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I have never been diagnosed with cancer.
I have a genetic condition that increases my cancer risk.
I am over 18 years old.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Connor Davidson Resilience Scale (CDRISC)
Secondary outcome measures
Acceptance and Action Questionnaire (AAQII)
Cantril/Gallup Life Evaluation Index
Other outcome measures
Cancer Behavior Inventory (CBI-B V2.0-12)
Generalized Anxiety Disorder-2 (GAD-2)
Net Promoter Score (NPS)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PreCharge Intervention PilotExperimental Treatment1 Intervention
After completing the baseline assessment, all pilot participants will have access to the PreCharge pilot program for 30 days. At the end of the 30 day pilot, they will be directed to the follow-up assessment.

Find a Location

Who is running the clinical trial?

Pro-Change Behavior SystemsLead Sponsor
16 Previous Clinical Trials
14,573 Total Patients Enrolled
~0 spots leftby Jul 2024